SCHEMBL31601685

SCHEMBL31601685

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 17/20 0.63
▸ NPY1R P25929 11/20 0.63
▸ NPY5R Q15761 9/20 0.63
▸ NPY2R P49146 7/20 0.63
▸ KISS1R Q969F8 1/20 0.42
▸ NOD1 Q9Y239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27639946 0.96 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29947104 0.96 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29655324 0.96 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL3138312 0.96 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30958046 0.96 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2R
SCHEMBL29794924 0.96 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2R
SCHEMBL3138301 0.96 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2R
SCHEMBL29531992 0.96 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30903458 0.95 NPY4R (0.57) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL30647286 0.95 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025120085-A1 MODULAR LINKER COMPOUND FOR TARGET-BINDING DRUG CONJUGATES HEIDELBERG PHARMA RESEARCH GMBH (DE) 2025-06-12 — — WO claimed
WO-2025120085-A1 MODULAR LINKER COMPOUND FOR TARGET-BINDING DRUG CONJUGATES HEIDELBERG PHARMA RESEARCH GMBH (DE) 2025-06-12 — — WO disclosed
WO-2025110752-A1 COMPOSITION FOR TREATING WOUND OR INHIBITING SKIN WRINKLE FORMATION 한도숙 2025-05-30 — — WO disclosed
Send feedback